Cidara’s Competitors, Revenue, Number of Employees, Funding, Acquisitions & News

Cidara develops and commercializes novel anti-infectives and immunotherapies for the treatment of fungal infections. Read more

Jeffrey Stein's photo - President & CEO of Cidara

President & CEO

Jeffrey Stein

CEO Approval Rating

90/100

Founded:

2012

Status:

PublicNASDAQCDTX

TOP COMPETITORS OR ALTERNATIVES

RANK

COMPANY

CEO

CEO RATING

EMPLOYEES

FUNDING

REVENUE

Missing a competitor? Contribute!

Scynexis is Cidara's #1 competitor. Scynexis's headquarters is in Jersey City, New Jersey, and was founded in 2000. Like Cidara, Scynexis also works within the Biotechnology sector. Scynexis generates 0.45% of Cidara's revenue.

Entasis is one of Cidara's top rivals. Entasis was founded in Waltham, Massachusetts} in 2018. Entasis operates in the Biotechnology industry. Compared to Cidara, Entasis generates $19.8M less revenue.

Amplyx is one of Cidara's top competitors. Amplyx is a Private company that was founded in 2006 in San Diego, California. Amplyx is in the Biotechnology industry. Compared to Cidara, Amplyx has 38 fewer employees.

Weigh-in!

Help the Owler community know more

Competitor - 1/1

Is Xellia a competitor of Cidara?

Quarterly and Annual Revenue

Trailing 12-Months Trend (TTM)

Annual Revenue

$26.8M

Cidara's revenue is the ranked 3rd among it's top 10 competitors. The top 10 competitors average 31.9M. Over the last four quarters, Cidara's revenue has decreased by 82.2%. Specifically, in Q2 2020's revenue was $3.4M; in Q1 2020, it was $2.5M; in Q4 2019, it was $1.8M; in Q3 2019, Cidara's revenue was $19.1M.

Acquisitions

No recent acquisitions found related to Cidara

Cidara Funding History

$30.3M$155.2M$175.2M$195.3M$196.9M$205.9M

Since Cidara was founded in 2012, it has participated in 8 rounds of funding. In total Cidara has raised $205.9M. Cidara's last funding round was on Sep 2019 for a total of $9.0M

ROUND

FUNDING DATE

AMOUNT

INVESTORS

Equity
Sep 2019
$9M
-
Unattributed
May 2018
$1.6M
-
Private Placement
Oct 2017
$20.2M
-
Debt
Nov 2016
$20M
Equity
May 2015
$6M

Total Funding: $205.9M

Since Cidara was founded in 2012, it has participated in 8 rounds of funding. In total Cidara has raised $205.9M. Cidara's last funding round was on Sep 2019 for a total of $9.0M

Investments

No recent investments found related to Cidara

Cidara News

July 17, 2020Benzinga

Cidara Therapeutics to Participate in B. Riley Virtual Summer Series Panel on Antiviral Therapeutics

SAN DIEGO, July 17, 2020 (GLOBE NEWSWIRE) -- Cidara Therapeutics, Inc. (NASDAQ:CDTX), a biotechnology... See more »
June 29, 2020BioSpace

Cidara Therapeutics Added to Russell 3000 Index

Cidara Therapeutics, Inc. (Nasdaq: CDTX), a biotechnology company developing long-acting therapeutics... See more »
June 23, 2020Benzinga

Winning Ways to Treat Infections and COVID-19

SAN DIEGO, June 23, 2020 (GLOBE NEWSWIRE) -- Cidara Therapeutics, Inc. (NASDAQ:CDTX), a biotechnology... See more »
June 11, 2020Benzinga

Cidara Therapeutics to Present at the Raymond James Human Health Innovations Conference

SAN DIEGO, June 11, 2020 (GLOBE NEWSWIRE) -- Cidara Therapeutics, Inc. (NASDAQ:CDTX), a biotechnology... See more »
May 25, 2020MarketScreener

Official notification to shareholders of matters to be brought to a vote ("Proxy")

(marketscreener.com) above and 52,592 shares held by Mr. Daruwala and 122,390 shares of common stock ... See more »
May 24, 2020MarketScreener

Maxim Group - Infectious Disease Virtual Conference

(marketscreener.com) New Hope for Serious Infections Maxim Group - Infectious Disease Virtual Confere... See more »
May 22, 2020Pharmabiz

Cidara begins patient dosing in phase 3 ReSPECT trial of rezafungin for prevention of invasive fungal disease in patients undergoing allogeneic BMT

Cidara Therapeutics, a biotechnology company, announced that the first patient has been dosed in its ... See more »

Cidara Press Releases

April 28, 2020GlobeNewswire

Cidara Therapeutics to Participate in Antifungal and COVID-19 Therapeutics Panels at Maxim Group's Infectious Disease Virtual Conference

SAN DIEGO, April 28, 2020 (GLOBE NEWSWIRE) -- Cidara Therapeutics, Inc. (Nasdaq: CDTX), a clinical-st... See more »
April 7, 2020GlobeNewswire

Cidara Therapeutics to Present at the 19th Annual Needham Virtual Healthcare Conference

SAN DIEGO, April 07, 2020 (GLOBE NEWSWIRE) -- Cidara Therapeutics, Inc. (Nasdaq: CDTX), a clinical-st... See more »
February 18, 2020GlobeNewswire

Cidara Therapeutics to Present at Transplantation & Cellular Therapy (TCT) and Mycology 2020 Medical Conferences

SAN DIEGO, Feb. 18, 2020 (GLOBE NEWSWIRE) -- Cidara Therapeutics, Inc. (Nasdaq: CDTX), a biotechnolog... See more »
November 18, 2019GlobeNewswire

Cidara Therapeutics Named a San Diego Metro Area Top Workplace for the Third Consecutive Year

Employee feedback places Cidara among top small companies in the areaEmployee feedback places Cidara ... See more »
November 5, 2019GlobeNewswire

Cidara Therapeutics Hosting Key Opinion Leader Meeting on Rezafungin and Cloudbreak Programs

SAN DIEGO, Nov. 05, 2019 (GLOBE NEWSWIRE) -- Cidara Therapeutics, Inc. (Nasdaq: CDTX), a biotechnolog... See more »
August 8, 2019GlobeNewswire

Cidara Provides Corporate Update and Reports Second Quarter 2019 Financial Results

SAN DIEGO, Aug. 08, 2019 (GLOBE NEWSWIRE) -- Cidara Therapeutics, Inc. (Nasdaq: CDTX), a biotechnolog... See more »
May 9, 2019GlobeNewswire

Cidara Provides Corporate Update and Reports First Quarter 2019 Financial Results

SAN DIEGO, May 09, 2019 (GLOBE NEWSWIRE) -- Cidara Therapeutics, Inc. (Nasdaq: CDTX), a biotechnology... See more »

Cidara Videos

Social Statistics

Headquarters

6310 Nancy Ridge Drive Suite 101

San Diego, California92121

1-858-752-6170

Driving Directions »

Trending Companies

Summary

ABOUT

Overview

Cidara develops and commercializes novel anti-infectives and immunotherapies for the treatment of fungal infections. Cidara was founded in 2012. Cidara's headquarters is located in San Diego, California, USA 92121. It has raised 205.9M in 8 rounds. Th...

CEO

Cidara's President & CEO, Jeffrey Stein, currently has an approval rating of 90%. Cidara's primary competitors are Scynexis, Entasis & Amplyx.

Website

cidara.com

Frequently Asked Questions about Cidara

  1. When was Cidara founded?

    Cidara was founded in 2012
  2. Who is Cidara's CEO?

    Cidara's CEO is Jeffrey Stein
  3. How much revenue does Cidara generate?

    Cidara generates $26.8M in revenue
  4. How much funding does Cidara have?

    Cidara has historically raised $205.9M in funding
  1. Where is Cidara's headquarters?

    Cidara's headquarters is in San Diego California, USA
  2. How many employees does Cidara have?

    Cidara has 68 employees
  3. What sector does Cidara operate in?

    Cidara is in Biotechnology
  4. Who are Cidara's competitors?

    Cidara's top competitors are Scynexis, Entasis, Amplyx